Sulfated polysaccharide from Gracilaria caudata reduces hypernociception and inflammatory response during arthritis in rodents.
Animals
Anti-Inflammatory Agents
/ chemistry
Arthritis, Experimental
/ drug therapy
Biomarkers
Capillary Permeability
/ drug effects
Disease Models, Animal
Edema
/ drug therapy
Freund's Adjuvant
Gracilaria
/ chemistry
Immunohistochemistry
Male
Mice
Polysaccharides
/ chemistry
Rodentia
Sulfates
/ chemistry
Zymosan
/ adverse effects
Arthritis
Cell migration
Gracilaria caudata
Hypernociception
Inflammation
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
received:
30
03
2020
revised:
21
05
2020
accepted:
08
06
2020
pubmed:
13
6
2020
medline:
30
3
2021
entrez:
13
6
2020
Statut:
ppublish
Résumé
Polysaccharide from marine alga Gracilaria caudata has potential health benefits, such as anti-inflammatory, gastroprotective and antidiarrheal effects. Here, we investigated the effect of a sulfated polysaccharide from G. caudata (SP-GC) on hypernociception and inflammatory response in arthritis models. The animals received SP-GC (3, 10 or 30 mg/kg) 1 h before tibio-tarsal injection of zymosan. Hypernociception, histopathology, edema, vascular permeability, myeloperoxidase (MPO) activity, cell influx, interleukin (IL)-1β and nitric oxide (NO) levels were evaluated in acute phase. In another protocol, animals received SP-GC (30 mg/kg) 2 h post-complete Freund's adjuvant (CFA). Hypernociception, edema and arthritis index were determined in acute, sub-chronic and chronic phases. Rota-rod test measured the motor performance. SP-GC significantly reduced, in a dose-dependent manner, the zymosan-induced hypernociception with maximal effect at 30 mg/kg. The microscopic inflammation, joint edema, MPO activity, cell influx, IL-1β and NO levels were also reduced by SP-GC. In the CFA-induced arthritis, SP-GC inhibits the hypernociception, edema and arthritic index in acute, sub-chronic and chronic phases. SP-GC did not alter the motor performance of animals. In conclusion, SP-GC exerts protective effect in models of arthritis due to the modulation of cell influx, IL-1β and NO levels, culminating in the reduction of hypernociception and edema.
Identifiants
pubmed: 32531369
pii: S0141-8130(20)33501-7
doi: 10.1016/j.ijbiomac.2020.06.060
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Biomarkers
0
Polysaccharides
0
Sulfates
0
Freund's Adjuvant
9007-81-2
Zymosan
9010-72-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1061-1069Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that there are no conflicts of interest.